NCT06072911 (CONTROL4LIFE) is a NA clinical trial of Pelvic floor exercise program in Prostate Cancer, sponsored by University of Alberta.

Who is sponsoring NCT06072911?

NCT06072911 is sponsored by University of Alberta.

What drugs are being tested in NCT06072911?

Interventions in NCT06072911: Pelvic floor exercise program, General exercise, Physical Activity Counseling.

What condition does NCT06072911 study?

NCT06072911 studies Prostate Cancer, Incontinence, Metabolic Disease.

Is NCT06072911 still recruiting?

NCT06072911 is currently recruiting now. Last updated 30 January 2026.

Last reviewed 2026-01-30 · How we verify

NCT06072911: CONTROL4LIFE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Continence, Sexual Function, Fitness and the Health of Men After Surgery for Prostate Cancer

Recruiting now NA Last updated 30 January 2026

What this trial tests

NA trial testing Pelvic floor exercise program in Prostate Cancer in 106 participants. Currently enrolling.

Timeline

27 February 2024

Primary endpoint
30 April 2026

30 June 2026

Quick facts

Lead sponsor	University of Alberta
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	supportive care
Enrollment	106
Start date	27 February 2024
Primary completion	30 April 2026
Estimated completion	30 June 2026
Sites	1 location across Canada

Drugs / interventions tested

Pelvic floor exercise program
General exercise
Physical Activity Counseling

Conditions studied

Prostate Cancer — all drugs for Prostate Cancer →
Incontinence — all drugs for Incontinence →
Metabolic Disease — all drugs for Metabolic Disease →

Sponsor

University of Alberta

Who can join

18 and older, male only, with Prostate Cancer or Incontinence. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Continence, Sexual and Metabolic Health (CONTROL 4 LIFE) study will evaluate the recovery of continence, sexual function, and health outcomes in individuals who have undergone surgery for prostate cancer. The purpose of this study is to better understand the timelines of recovery for these outcomes after surgery for prostate cancer. As part of this study, all participants will receive resources offered by Alberta Health Services regarding pre- and post-prostatectomy care, including information on pelvic floor exercises. Through the CONTROL 4 LIFE study, the investigators will also be evaluating outcomes related to physical activity, fitness and quality of life. These assessments will enable the investigators to better understand how well and how long it takes for individuals to recover after surgery for prostate cancer.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Control4Life: A randomized controlled trial protocol examining the feasibility and efficacy of a combined pelvic health rehabilitation and exercise fitness program for individuals undergoing prostatectomy.
Bernard S, Evans H, Hoy NY, Suderman K, et al · · 2024 · cited 1× · PMID 38431130 · DOI 10.1016/j.cct.2024.107482

Verify or expand the search:

Other recruiting trials for Prostate Cancer

Currently open trials in the same condition.

NCT06960798 — Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno) · recruiting
NCT07237269 — Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer · Phase 2 · recruiting
NCT07234981 — PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer · Phase 2 · recruiting
NCT07027124 — Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Ris · Phase 2 · recruiting
NCT07426094 — PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate · Phase 2, PHASE3 · recruiting

Other University of Alberta trials

Trials by the same sponsor.

NCT03240900 — Electrical Stimulation for Improving Postoperative Breast Sensation · NA · not yet recruiting
NCT04231760 — The Effect of Inhaled Nitric Oxide on Pulmonary Gas-exchange in COPD · Phase 1, PHASE2 · not yet recruiting
NCT06649604 — Reducing Pain From Retinal Laser With Vibrational Stimulation · NA · not yet recruiting
NCT06824077 — Reducing Days DELirious With DEXmedetomidine as Part of an Intensive Care Unit Sleep Promotion Bundle · EARLY_PHASE1 · not yet recruiting
NCT06920914 — Effects of Minimally vs. Ultra-Processed Diets on Potassium (K) Handling in CKD · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06072911 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Alberta
Last refreshed: 30 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06072911.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing